Thermo Fisher Scientific
TMO
2,527 hedge funds and large institutions have $196B invested in Thermo Fisher Scientific in 2024 Q1 according to their latest regulatory filings, with 192 funds opening new positions, 1,015 increasing their positions, 962 reducing their positions, and 121 closing their positions.
59% more first-time investments, than exits
New positions opened: 192 | Existing positions closed: 121
2% more funds holding
Funds holding: 2,487 → 2,527 (+40)
6% more repeat investments, than reductions
Existing positions increased: 1,015 | Existing positions reduced: 962
4% more capital invested
Capital invested by funds: $188B → $196B (+$7.31B)
3.53% less ownership
Funds ownership: 91.82% → 88.29% (-3.5%)
9% less funds holding in top 10
Funds holding in top 10: 141 → 128 (-13)
20% less call options, than puts
Call options by funds: $1.1B | Put options by funds: $1.39B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$883M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$691M |
| 3 |
Polen Capital Management
Boca Raton,
Florida
|
+$688M |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$462M |
| 5 |
BlackRock
New York
|
+$365M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$7.49B |
| 2 |
TCI Fund Management
London,
United Kingdom
|
-$914M |
| 3 |
Swedbank
Stockholm,
Sweden
|
-$640M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$523M |
| 5 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$352M |
TMO Hedge Fund Activity: Q1 2024 in Review
2,527 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q1 2024, worth a combined $196B — up 3.9% from $188B a quarter earlier.
Buyers outnumbered sellers: 192 funds opened new TMO positions and 121 closed out — a net gain of 71 holders — while 1,015 added to existing stakes and 962 trimmed.
The largest buyer was Franklin Resources, adding an estimated $883M. The largest seller was Morgan Stanley, cutting an estimated $7.49B.
- 2,527 institutional investors held Thermo Fisher Scientific (TMO) as of Q1 2024, up from 2,487 in Q4 2023.
- Funds reported $196B of Thermo Fisher Scientific stock for Q1 2024, up 3.9% quarter-over-quarter.
- 192 funds opened new Thermo Fisher Scientific positions in Q1 2024 and 121 closed out, a net change of +71 holders.
- The largest Thermo Fisher Scientific buyer in Q1 2024 was Franklin Resources, an estimated $883M added.
- The largest Thermo Fisher Scientific seller in Q1 2024 was Morgan Stanley, an estimated $7.49B sold.
Based on aggregated 13F filings for Q1 2024.